Viridian Therapeutics, Inc. (VRDN)
17.62
+0.17
(+0.97%)
USD |
NASDAQ |
May 29, 16:00
17.82
+0.20
(+1.14%)
After-Hours: 20:00
Viridian Therapeutics EPS Diluted (Quarterly) : -1.026 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 3.344 |
| Spyre Therapeutics, Inc. | -0.8785 |
| Praxis Precision Medicines, Inc. | -3.205 |
| CAMP4 Therapeutics Corp. | -0.3165 |
| Savara, Inc. | -0.1472 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -104.90M |
| Revenue (Quarterly) | 0.141M |
| Total Expenses (Quarterly) | 105.04M |
| Enterprise Value | 1.367B |
| Gross Profit Margin (Quarterly) | 14.18% |
| Profit Margin (Quarterly) | -74.40K% |
| Earnings Yield | -21.36% |
| Normalized Earnings Yield | -21.63 |